“Medical, nutritional and technological properties of lactulose. An update”. European Journal of Nutrition41 Suppl 1: I17-25. (November 2002). doi:10.1007/s00394-002-1103-6. PMID12420112.
“Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy”. Alimentary Pharmacology & Therapeutics33 (6): 662–71. (March 2011). doi:10.1111/j.1365-2036.2010.04574.x. PMID21251030.
“Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children”. Seizure15 (6): 443–8. (September 2006). doi:10.1016/j.seizure.2006.05.007. PMID16787750.
“Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders”. Alimentary Pharmacology & Therapeutics30 (2): 165–74. (July 2009). doi:10.1111/j.1365-2036.2009.04018.x. PMID19392860.
“Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo”. Gastroenterology137 (3): 885–91, 891.e1. (September 2009). doi:10.1053/j.gastro.2009.05.056. PMID19501587.
“Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy”. Hepatology45 (3): 549–59. (March 2007). doi:10.1002/hep.21533. PMID17326150.
drugs.com
“Lactulose”. The American Society of Health-System Pharmacists. 2017年9月4日時点のオリジナルよりアーカイブ。2015年8月11日閲覧。
“Medical, nutritional and technological properties of lactulose. An update”. European Journal of Nutrition41 Suppl 1: I17-25. (November 2002). doi:10.1007/s00394-002-1103-6. PMID12420112.
“Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy”. Alimentary Pharmacology & Therapeutics33 (6): 662–71. (March 2011). doi:10.1111/j.1365-2036.2010.04574.x. PMID21251030.
“Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children”. Seizure15 (6): 443–8. (September 2006). doi:10.1016/j.seizure.2006.05.007. PMID16787750.
“The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin”. The American Journal of Gastroenterology103 (4): 964–5. (April 2008). PMID18371132.
“Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders”. Alimentary Pharmacology & Therapeutics30 (2): 165–74. (July 2009). doi:10.1111/j.1365-2036.2009.04018.x. PMID19392860.
“Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo”. Gastroenterology137 (3): 885–91, 891.e1. (September 2009). doi:10.1053/j.gastro.2009.05.056. PMID19501587.
“Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy”. Hepatology45 (3): 549–59. (March 2007). doi:10.1002/hep.21533. PMID17326150.